Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

One day after a subcutaneous injection into the left thigh, she developed a mildly pruritic eruption on the right thigh, at the site of a previous injection. Etanercept (Enbrel ®) is an ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

The biosimilar's safety and immunogenicity profiles were found to be comparable to those of the reference product in the ...

Achondroplasia, which affects around one in 20,000 babies, has just one approved treatment: BioMarin’s Voxzogo. However, new ...

Nucala (mepolizumab) is a brand-name subcutaneous injection that comes ... Before injecting Nucala, you’ll need to clean the injection site with an alcohol swab and let it air-dry.

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

Primary results of phase 3 AURIGA study indicated that dual maintenance therapy after transplant led to improved outcomes.

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...

The investigation has enrolled 532 patients with relapsed/refractory myeloma across 252 global sites. Eligible adult patients who ... device that is thinner compared with commonly used subcutaneous ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

The Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults.